Tranexamic Acid
Product Images NDC 63323-563

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 63323-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tra12 0002 01

FDA Label Image

Tra12 0002 02

FDA Label Image

Tra12 0002 03

This is a medication with NDC number 63323-563-01 used for Intravenous Use. It is a single dose vial containing Tranexamic Acid, with each mL having 100mg/mL of the active ingredient. It is manufactured by Fresenius Kabi in Lake Zurich, Illinois. The natural rubber latex is not used in the manufacturing of the container closure. LOT/EXP information is also provided.*

FDA Label Image

Tra12 0002 04

Tranexamic Acid Injection USP is a medication for intravenous use only that contains Tranexamic acid. The medication comes in 10 x 10 mL single-dose vials where each mL contains 100 mg active Tranexamic acid and inactive water for injection. The medication should be discarded after use. The usual dosage should be followed as mentioned in the package insert. The medication should be stored at 20°C to 25°C (68°F to T7°F), and excursions to 15°C to 30°C (59°F to 86°F) are permitted as per USP Controlled Room Temperature. The container closure is not made of natural rubber latex. The manufacturer of this medication is Fresenius Kabi, Lake Zurich, IL 60047.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.